Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| retina horizontal cell | 6 studies | 45% ± 12% | |
| GABAergic neuron | 6 studies | 40% ± 19% | |
| glutamatergic neuron | 5 studies | 44% ± 20% | |
| oligodendrocyte precursor cell | 5 studies | 27% ± 9% | |
| interneuron | 4 studies | 37% ± 16% | |
| neuron | 3 studies | 25% ± 7% | |
| astrocyte | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 34% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 6543.14 | 2640 / 2642 | 99% | 142.29 | 695 / 705 |
| adrenal gland | 0% | 5.25 | 1 / 258 | 20% | 8.87 | 45 / 230 |
| skin | 8% | 67.26 | 141 / 1809 | 1% | 0.61 | 4 / 472 |
| uterus | 0% | 0 | 0 / 170 | 2% | 1.25 | 10 / 459 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.60 | 1 / 80 |
| pancreas | 0% | 0 | 0 / 328 | 1% | 0.52 | 2 / 178 |
| ovary | 0% | 0 | 0 / 180 | 0% | 0.12 | 2 / 430 |
| intestine | 0% | 0 | 0 / 966 | 0% | 0.10 | 2 / 527 |
| lung | 0% | 0 | 0 / 578 | 0% | 0.07 | 3 / 1155 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.10 | 1 / 406 |
| bladder | 0% | 0 | 0 / 21 | 0% | 0.05 | 1 / 504 |
| thymus | 0% | 0 | 0 / 653 | 0% | 0.02 | 1 / 605 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| breast | 0% | 0 | 0 / 459 | 0% | 0 | 0 / 1118 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| esophagus | 0% | 0 | 0 / 1445 | 0% | 0 | 0 / 183 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| stomach | 0% | 0 | 0 / 359 | 0% | 0 | 0 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0043488 | Biological process | regulation of mRNA stability |
| GO_1903861 | Biological process | positive regulation of dendrite extension |
| GO_0098970 | Biological process | postsynaptic neurotransmitter receptor diffusion trapping |
| GO_0099590 | Biological process | neurotransmitter receptor internalization |
| GO_2000311 | Biological process | regulation of AMPA receptor activity |
| GO_0098943 | Biological process | neurotransmitter receptor transport, postsynaptic endosome to lysosome |
| GO_0051968 | Biological process | positive regulation of synaptic transmission, glutamatergic |
| GO_0019226 | Biological process | transmission of nerve impulse |
| GO_0099645 | Biological process | neurotransmitter receptor localization to postsynaptic specialization membrane |
| GO_0006816 | Biological process | calcium ion transport |
| GO_0070588 | Biological process | calcium ion transmembrane transport |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0098839 | Cellular component | postsynaptic density membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_1990454 | Cellular component | L-type voltage-gated calcium channel complex |
| GO_0005769 | Cellular component | early endosome |
| GO_0032281 | Cellular component | AMPA glutamate receptor complex |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0005891 | Cellular component | voltage-gated calcium channel complex |
| GO_0044300 | Cellular component | cerebellar mossy fiber |
| GO_0005246 | Molecular function | calcium channel regulator activity |
| GO_0005245 | Molecular function | voltage-gated calcium channel activity |
| GO_0016247 | Molecular function | channel regulator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CACNG7 |
| Protein name | Voltage-dependent calcium channel gamma-7 subunit (Neuronal voltage-gated calcium channel gamma-7 subunit) (Transmembrane AMPAR regulatory protein gamma-7) (TARP gamma-7) Voltage-dependent calcium channel gamma-7 subunit |
| Synonyms | |
| Description | FUNCTION: Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit . Regulates the trafficking and gating properties of AMPA-selective glutamate receptors (AMPARs). Promotes their targeting to the cell membrane and synapses and modulates their gating properties by slowing their rates of activation, deactivation and desensitization and by mediating their resensitization. Displays subunit-specific AMPA receptor regulation. Shows specificity only for GRIA1 and GRIA2 . . FUNCTION: Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit (By similarity). Regulates the trafficking and gating properties of AMPA-selective glutamate receptors (AMPARs). Promotes their targeting to the cell membrane and synapses and modulates their gating properties by slowing their rates of activation, deactivation and desensitization and by mediating their resensitization. Shows specificity only for GRIA1 and GRIA2. . |
| Accessions | P62955 ENST00000391766.1 ENST00000391767.6 A0A0C4DFY2 ENST00000222212.6 |
